Canada: The Requirement Of Causation In An Accounting Of Profits – Federal Court Of Appeal Rules On Availability Of Non-Infringing Alternatives And Apportionment Of Non-Infringing Services

Last Updated: March 28 2017
Article by R. Scott MacKendrick and Anastassia Trifonova

In a recent patent accounting of profits decision of the Federal Court of Appeal in Apotex Inc v ADIR, 2017 FCA 23, the Court emphasized that the profits need to be causally attributable to the invention. The Court also dealt with: 1) the availability of non-infringing alternatives on export sales; and 2) the apportionment of profit from the provision of indemnity and legal services.

The accounting of profits arose from a decision that found that Apotex Inc. and Apotex Pharmachem Inc. (collectively "Apotex") infringed Canadian Patent No. 1,341,196 ("196 Patent"). The 196 Patent covered perindopril and is owned by ADIR, and Servier Canada Inc. was a person claiming under the patentee (collectively "Servier"). Following the liability determination, Servier elected to recover Apotex's profits as a result of Apotex's infringing activities.

On June 18, 2015, Justice Gagné of the Federal Court ordered Apotex to pay to Servier over $61 million dollars in profits attributable to the infringement of the 196 Patent. Justice Gagné considered Apotex's Canadian profits as well as profits from the sale of perindopril tablets abroad, particularly to Apotex's affiliates located in Australia and UK.

The issue for the Federal Court of Appeal was the determination of the profits earned by Apotex on export sales. Specifically, Apotex argued that Justice Gagné erred in failing to consider non-infringing alternatives to the infringing perindopril and in failing to discount profits earned from provision of non-infringing services.

Availability of Non-Infringing Alternatives

At trial, Justice Gagné considered Apotex's assertion that there were "a number of viable, non-infringing alternative sources" of perindopril. However, she rejected Apotex's argument that its profits should be calculated by taking into account the availability of non-infringing perindopril for export sales.

On appeal, the Federal Court of Appeal noted that in Monsanto Canada Inc v Schmeiser, 2004 SCC 34:

 "...the Supreme Court referred to the differential profit approach as the "preferred means" of calculating an accounting of profits – not the only means. However, at bottom is the need to ensure that a patentee only receives that portion of the infringer's profit that is causally attributable to the invention." [emphasis added]

The Federal Court of Appeal accepted Apotex's argument that the value of the invention can "only be quantified if non-infringing alternatives are considered" and held that it was an error not to take into account the availability of non-infringing perindopril for export sales.

The Federal Court of Appeal then analyzed Justice Gagné's assessment of the evidence. In doing so, it endorsed the causation analysis used in Apotex Inc v Merck & Co, Inc, 2015 FCA 171 and Pfizer Canada Inc v Teva Canada Limited, 2016 FCA 161. In those decisions, compensatory damages and damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations, respectively, were being considered. The Federal Court of Appeal held that the damages causation approach used in those decisions had equal application in the context of accounting of profits. For a summary of the Federal Court of Appeal decision in Apotex Inc v Merck & Co, Inc, and its damages causation approach, please see "But for", "Could" and "Would": The Patent Damages Approach to Non-infringing Alternatives. The Federal Court of Appeal concluded that the trial judge failed to adequately consider the evidence as to the ability of Apotex's suppliers to provide non-infringing perindopril and remitted the issue of non-infringing alternatives back to the Federal Court.

Apportionment of Non-Infringing Services

As part of its defence, Apotex also argued that the revenue it received under the transfer price agreements for the sale of perindopril to its affiliates in UK and Australia should be apportioned. Apotex asserted that since perindopril was a "Patent Challenge Product" and carried a heightened risk of litigation, the higher price paid by its UK and Australian affiliates for perindopril was due to the indemnity provision and related litigation services. Justice Gagné rejected this argument and found that the heightened transfer price was due to the sale of the drug itself.

On appeal, the Federal Court of Court concluded that the apportionment would not be appropriate on the facts of this case because, "but for" its infringing activities, Apotex would not have made any profit.

What drove Apotex' sales of perindopril were the new and useful characteristics of the drug. Had perindopril not been protected by the 196 Patent, there would have been no need for Apotex to provide an indemnity to protect the fragility of its affiliates. "But for" the infringing qualities of perindopril, Apotex would have earned nothing on its sale, whether attributable to the drug itself or to the indemnity required to protect the affiliates. Thus, the profit resulting from the sale of perindopril was entirely causally attributable to the invention. It follows that no apportionment is warranted. [emphasis added]

The Federal Court of Appeal held that even though the trial judge committed an extricable error of law in interpreting the contracts between Apotex and its affiliates, the need for a larger price "where the litigation risk loomed large" did not establish that Apotex's affiliates agreed to pay the difference between the Patent Challenge Product price and the non-infringing patent price solely in exchange for Apotex's protection. The Court noted that for any agreement to apportion the revenue in such a way, the agreement "should have precisely set out what was to be paid for what".

In summary, the Federal Court of Appeal's decision reaffirms the settled law that a patentee is only entitled to a portion of the infringer's profit that is causally attributable to the invention when accounting of profits is elected, and this causal attribution requirement bears both on the consideration of non-infringing alternatives and apportionment.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

R. Scott MacKendrick
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.